Apc変異細胞からのNOTUMは,癌を誘発するクローン競争に偏っている
Dustin J Flanagan1, Nalle Pentinmikko2,3, Kalle Luopajärvi2,3
1Cancer Research UK Beatson Institute, Glasgow, UK.
Nature
|June 3, 2021
まとめ
大腸がんの Apc変異細胞は NOTUM を使用してワイルド型細胞を抑制し,競争上の優位性を獲得します. NOTUMの抑制は腫瘍の成長を阻害し,潜在的な予防戦略を提供します.
科学分野:
- 腫瘍学
- 分子生物学
- 遺伝学
背景:
- 腫瘍抑制剤であるAdenomatous Polyposis Coli (APC) は,大腸がん (CRC) で頻繁に変異する.
- 腸の幹細胞におけるAPCの喪失は,WNTシグナル伝達を通じてアデノマの形成を促進するが,逆説的に,減少したWNTリガンド分泌は,変異細胞のコロニー化 (固定) を助長する.
研究 の 目的:
- Apc変異細胞がクローン上の優位性と腸内密室の固定性を獲得するメカニズムを調査する.
- Apc変異細胞の拡大を可能とする分子媒介者を特定する.
主な方法:
- Apc変異体と野生型の腸内細胞のトランスクリプトミックの分析
- In vitro オーガノイド培養と条件付け媒体の実験
- NOTUMの遺伝的または薬学的阻害を含むインビボ試験.
主要な成果:
- Apc変異細胞は,WNT抗体トランスクリプト,特にNOTUMの濃縮を示した.
- Apc変異細胞からの条件付け媒体は,NOTUM経由で,野生型オーガノイドの増殖を抑制した.
- NOTUMを分泌する Apc-変異性クローンは,野生型の細胞の増殖を抑制し,分化を促進し,ニッチ占拠の競争に勝った.
結論:
- NOTUMは,大腸がんにおけるApc変異細胞の早期固定における重要な媒介である.
- NOTUMをターゲットにすることで,野生型の細胞の競争力を回復し,アデノマの形成を抑制できます.
- NOTUMの抑制は,CRCのリスクが高い個人に潜在的な予防戦略を提示します.
関連する概念動画
Cancers Originate from Somatic Mutations in a Single Cell
13.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.4K
Cancer
51.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.3K
Abnormal Proliferation
4.8K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Cancer-Critical Genes I: Proto-oncogenes
9.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.5K
Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K


